發(fā)布時間：2018-04-21 08:30

  本文選題：經(jīng)腋中線 + 上中胸椎腫瘤��； 參考：《廣西醫(yī)科大學(xué)》2015年碩士論文

【摘要】：目的：探討經(jīng)腋中線胸腔入路手術(shù)治療上中胸椎腫瘤手術(shù)方式及臨床療效分析。方法：1、按選入標(biāo)準(zhǔn)選取2012年2月至2014年12月在我科住院手術(shù)的上中胸椎腫瘤(T2-T6)患者7例。采用經(jīng)腋中線胸腔入路腫瘤病灶切除,植骨融合,鈦籠鈦板內(nèi)固定治療。觀察手術(shù)切口長度、術(shù)野顯露、出血量、手術(shù)時間、神經(jīng)減壓情況、胸腔引流量、術(shù)后并發(fā)癥情況,以及術(shù)前、術(shù)后隨訪Frankel評分、VAS評分情況。術(shù)后隨訪2-27個月。2、通過SPSS21.0對數(shù)據(jù)進行分析,檢驗數(shù)據(jù)是否正態(tài)時檢驗水準(zhǔn)為a=0.1,當(dāng)p0.1時數(shù)據(jù)呈正態(tài)分布；其余數(shù)據(jù)統(tǒng)計對比檢驗水準(zhǔn)為a=0.05,當(dāng)p0.05時有統(tǒng)計學(xué)差異。結(jié)果：全部7例患者均能通過腋中線胸腔入路順利完成上中胸椎椎體的顯露和病灶切除以及完成椎體間的植骨融合和鈦籠鈦板內(nèi)固定的植入。該入路顯露范圍可達T1下緣至T7上緣,能夠?qū)2-T6的病灶進行相應(yīng)的手術(shù)操作,未出現(xiàn)術(shù)中及術(shù)后并發(fā)癥�；颊咴谛g(shù)后隨訪中VAS評分和Frankel神經(jīng)功能分級均有一定程度的改善,有統(tǒng)計學(xué)差異(P0.05)。結(jié)論：經(jīng)腋中線胸腔入路治療上中胸椎椎體腫瘤具有視野開闊,病變節(jié)段顯露清楚,病灶清除徹底,內(nèi)固定操作簡易,神經(jīng)減壓滿意,固定牢靠,并發(fā)癥少等優(yōu)點,具有實踐價值,是手術(shù)治療上中胸椎椎體腫瘤的一種新的思路。
[Abstract]:Objective: To investigate the surgical methods and clinical effects of thoraco thoracic surgery in the treatment of upper and middle thoracic tumors. Methods: 1, 7 cases of upper middle thoracic tumors (T2-T6) were selected from February 2012 to December 2014 in our department in accordance with the selection criteria. The tumor resection, bone fusion, titanium cage titanium plate and titanium cage were used. Fixed treatment. Observation of surgical incision length, operation field exposure, bleeding volume, operation time, nerve decompression, thoracic drainage, postoperative complications, and preoperative, follow-up Frankel score, VAS score, 2-27 months after the operation.2, the data were analyzed by SPSS21.0, the test data were normal when the test level was a=0.1, when p, when p At 0.1, the data showed a normal distribution; the rest of the data was a=0.05, and there was a statistical difference when P0.05. Results: all the 7 patients were able to successfully complete the upper middle thoracic vertebral body exposure and the lesion resection through the midline thoracic approach, and complete the interbody fusion and titanium cage titanium plate internal fixation. The exposure range can reach the lower edge of T1 to the upper edge of T7, and it can operate on the T2-T6 focus. There is no intraoperative and postoperative complications. The VAS score and the Frankel nerve function grade are improved to a certain extent in the postoperative follow-up, and there are statistical differences (P0.05). Conclusion: midline thoracic approach is used to treat the upper and middle thoracic vertebral body swollen. The tumor has a wide field of vision, clear lesion segment, thorough clearing of the lesion, simple internal fixation, satisfactory nerve decompression, fixed fixation, less complications and so on. It is of practical value. It is a new idea for the surgical treatment of upper thoracic vertebra tumor.

【學(xué)位授予單位】：廣西醫(yī)科大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2015
【分類號】：R738

【參考文獻】

相關(guān)期刊論文 前10條

1 陳華江,肖建如,賈連順;原發(fā)性脊柱腫瘤外科治療現(xiàn)狀與進展[J];國外醫(yī)學(xué).骨科學(xué)分冊;2003年03期

2 李彥;姜亮;劉曉光;劉忠軍;韋峰;吳奉梁;黨y;;肺癌脊柱轉(zhuǎn)移瘤的手術(shù)治療療效及生存分析[J];北京大學(xué)學(xué)報(醫(yī)學(xué)版);2014年01期

3 莊平;丁真奇;康兩奇;郭志民;;經(jīng)胸骨柄“U”形開窗入路顯露上胸椎的應(yīng)用解剖[J];解剖與臨床;2008年03期

4 劉柱同;矢慶明;殷明;顧玉榮;吳慶;;肩胛下高位經(jīng)胸腔入路治療上胸椎病變的療效觀察[J];江西醫(yī)學(xué)院學(xué)報;2007年02期

5 覃繼祖;;雙腔氣管導(dǎo)管麻醉的療效分析[J];臨床醫(yī)藥文獻電子雜志;2015年04期

6 肖建如,賈連順,袁文,陳德玉,倪斌,趙定麟;頸椎原發(fā)性骨腫瘤的外科分期及其手術(shù)治療[J];中華骨科雜志;2001年11期

7 葉曉健,賈連順,袁文,何海龍,李家順;改良Sundaresan法治療上胸椎腫瘤[J];中華骨科雜志;2004年08期

8 陳堅,胡瀛洲,屠重棋,裴福興;經(jīng)肩胛下胸腔入路的上胸椎腫瘤切除及脊柱穩(wěn)定性重建術(shù)[J];中國矯形外科雜志;2001年10期

9 夏虹;尹慶水;潘剛明;張卓華;昌耘冰;劉暉;廖穗祥;劉景發(fā);;上胸段病變的經(jīng)胸骨前入路手術(shù)治療[J];中國矯形外科雜志;2007年17期

10 趙明偉;馬廣仁;徐鵬;劉朝陽;王軍;;兩種剖胸入路在胸椎結(jié)核手術(shù)中的應(yīng)用探討[J];中國矯形外科雜志;2010年05期

相關(guān)碩士學(xué)位論文 前1條

1 賀大銀;非甾體抗炎藥用于術(shù)后鎮(zhèn)痛的臨床研究[D];第四軍醫(yī)大學(xué);2004年

，

本文編號：1781669